Peter Barth

673 total citations
45 papers, 404 citations indexed

About

Peter Barth is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Peter Barth has authored 45 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Hematology and 8 papers in Surgery. Recurrent topics in Peter Barth's work include Multiple Myeloma Research and Treatments (12 papers), Cancer Treatment and Pharmacology (5 papers) and Protein Degradation and Inhibitors (5 papers). Peter Barth is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Cancer Treatment and Pharmacology (5 papers) and Protein Degradation and Inhibitors (5 papers). Peter Barth collaborates with scholars based in United States, Germany and Greece. Peter Barth's co-authors include Adam J. Olszewski, John L. Reagan, Daniel M. Geynisman, Yu‐Ning Wong, G.P. McGregor, M Rothmund, Burkhard Göke, M. M. Byrne, Alexander Bockmayr and Rudolf Arnold and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Peter Barth

40 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Barth United States 10 99 77 65 61 51 45 404
Masaki Yamamoto Japan 15 137 1.4× 74 1.0× 241 3.7× 48 0.8× 127 2.5× 94 825
D.L. Bisset United Kingdom 10 51 0.5× 11 0.1× 82 1.3× 33 0.5× 32 0.6× 35 360
Henry D. Friedman United States 13 80 0.8× 37 0.5× 66 1.0× 57 0.9× 21 0.4× 26 456
Márcia A. Inda Netherlands 11 74 0.7× 14 0.2× 11 0.2× 46 0.8× 87 1.7× 24 333
B. Mahr Austria 15 36 0.4× 67 0.9× 26 0.4× 19 0.3× 62 1.2× 36 553
Diana Quinlan Canada 12 192 1.9× 9 0.1× 69 1.1× 87 1.4× 57 1.1× 27 886
Kartik Anand United States 13 274 2.8× 8 0.1× 67 1.0× 24 0.4× 115 2.3× 40 562
Athanasios Papadopoulos Greece 10 78 0.8× 5 0.1× 34 0.5× 36 0.6× 20 0.4× 31 332
Joakim Johansson Sweden 15 29 0.3× 18 0.2× 336 5.2× 31 0.5× 82 1.6× 37 931
Michael Homer New Zealand 15 89 0.9× 23 0.3× 9 0.1× 29 0.5× 7 0.1× 65 616

Countries citing papers authored by Peter Barth

Since Specialization
Citations

This map shows the geographic impact of Peter Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Barth more than expected).

Fields of papers citing papers by Peter Barth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Barth. The network helps show where Peter Barth may publish in the future.

Co-authorship network of co-authors of Peter Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Barth. A scholar is included among the top collaborators of Peter Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Barth. Peter Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Körperich, Hermann, et al.. (2024). Assessing diastolic function using CMR as an alternative to echocardiography: age- and gender-related normal reference values. Clinical Research in Cardiology. 114(12). 1641–1657.
4.
Barth, Peter, Smith Giri, John L. Reagan, & Adam J. Olszewski. (2020). Outcomes of lenalidomide‐ or bortezomib‐based regimens in older patients with plasma cell myeloma. American Journal of Hematology. 96(1). 14–22. 3 indexed citations
5.
Giri, Smith, Peter Barth, Luciano J. Costa, & Adam J. Olszewski. (2020). Second primary malignancy among older adults with multiple myeloma receiving first-line lenalidomide-based therapy: A population-based analysis. Journal of Geriatric Oncology. 12(2). 256–261. 1 indexed citations
6.
Giri, Smith, Peter Barth, Luciano J. Costa, & Adam J. Olszewski. (2019). Second Primary Malignancy Among Patients with Plasma Cell Myeloma Receiving First-Line Lenalidomide-Based Therapy: A Population-Based Analysis. Blood. 134(Supplement_1). 1862–1862. 1 indexed citations
7.
Olszewski, Adam J., et al.. (2019). Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia. Blood. 134(Supplement_1). 3511–3511. 6 indexed citations
8.
Safran, Howard, Kimberly Perez, Matthew Vrees, et al.. (2018). Tolerability of ADXS11-001 Lm -LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1175–1178. 28 indexed citations
9.
Barth, Peter, et al.. (2018). The Next Generation of Therapy for Multiple Myeloma: A Review of Ongoing Clinical Trials Utilizing Clinicaltrials.gov. Future Oncology. 14(19). 1965–1976. 4 indexed citations
11.
Zibelman, Matthew R., Peter Barth, Elizabeth A. Handorf, et al.. (2014). A Review of Interventional Clinical Trials in Renal Cell Carcinoma: A Status Report From the ClinicalTrials.gov WebSite. Clinical Genitourinary Cancer. 13(2). 142–149. 7 indexed citations
12.
Görg, Christian, et al.. (2010). Kontrastunterstützte sonografische Befunde bei hepatischer Candidiasis. Zeitschrift für Gastroenterologie. 48(6). 678–682. 9 indexed citations
13.
Huynh, Minh, et al.. (2009). B-Mode Ultrasound and Contrast-Enhanced Ultrasound Pattern of Focal Extramedullary Hematopoiesis of the Spleen in a Patient with Myeloproliferative Disease. Ultraschall in der Medizin - European Journal of Ultrasound. 30(3). 297–299. 2 indexed citations
14.
Byrne, M. M., G.P. McGregor, Peter Barth, et al.. (2001). Intestinal Proliferation and Delayed Intestinal Transit in a Patient with a GLP-1-, GLP-2- and PYY-Producing Neuroendocrine Carcinoma. Digestion. 63(1). 61–68. 34 indexed citations
15.
Barth, Peter & Alexander Bockmayr. (1998). Modelling discrete optimisation problems inconstraint logic programming. Annals of Operations Research. 81(0). 467–496. 7 indexed citations
16.
Barth, Peter & Alexander Bockmayr. (1997). PLAM: ProLog and Algebraic Modelling. Untitled Event. 128(3). 73–82. 1 indexed citations
17.
Barth, Peter, et al.. (1996). [Subacute distal motor neuropathy disclosing malignant non-Hodgkin lymphoma: improvement under chemotherapy].. PubMed. 152(3). 208–10. 3 indexed citations
18.
Barth, Peter & Alexander Bockmayr. (1995). Modelling mixed-integer optimisation problems in constraint logic programming. MPG.PuRe (Max Planck Society). 4 indexed citations
19.
Wagner, Hans‐Joachim, Peter Barth, Carmen Schade‐Brittinger, Sven Plein, & Klaus‐Jochen Klose. (1995). Postmortem evaluation of four randomly selected automated biopsy devices for transthoracic lung biopsy. CardioVascular and Interventional Radiology. 18(5). 300–6. 8 indexed citations
20.
Barth, Peter, et al.. (1991). [Techniques for ultrasound imaging of meniscus lesions. Experimental principles].. PubMed. 94(2). 63–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026